Myriad Genetics Inc banner

Myriad Genetics Inc
DUS:MYD

Watchlist Manager
Myriad Genetics Inc Logo
Myriad Genetics Inc
DUS:MYD
Watchlist
Price: 4.22 EUR -0.47% Market Closed
Market Cap: €379.4m

Wall Street
Price Targets

MYD Price Targets Summary
Myriad Genetics Inc

Wall Street analysts forecast MYD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MYD is 6.6 EUR with a low forecast of 2.97 EUR and a high forecast of 15.89 EUR.

Lowest
Price Target
2.97 EUR
30% Downside
Average
Price Target
6.6 EUR
57% Upside
Highest
Price Target
15.89 EUR
277% Upside
Myriad Genetics Inc Competitors:
Price Targets
DXPE
DXP Enterprises Inc
-21% Downside
CIGI
Colliers International Group Inc
-6% Downside
SUPN
Supernus Pharmaceuticals Inc
22% Upside
WLFC
Willis Lease Finance Corp
-20% Downside
SMCP
SMCP SA
20% Upside

Revenue
Forecast

7% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
7% / Year
Past Growth
4% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 4 years is 4%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MYD's stock price target?
Price Target
6.6 EUR

According to Wall Street analysts, the average 1-year price target for MYD is 6.6 EUR with a low forecast of 2.97 EUR and a high forecast of 15.89 EUR.

What is Myriad Genetics Inc's Revenue forecast?
Projected CAGR
4%

For the last 3 years the compound annual growth rate for Myriad Genetics Inc's revenue is 7%. The projected CAGR for the next 4 years is 4%.

Back to Top